Northwest Biotherapeutics

Northwest Biotherapeutics NWBO Stock

$0.15   -1.292519%
Add to favorites
Market Cap
$247.49M
LOW - HIGH [24H]
$0.15 - $0.16
VOLUME [24H]
$1.27M
P/E Ratio
0
Earnings per share
-$0.03
ISIN
US66737P6007
Price   Prediction

Northwest Biotherapeutics Price Chart

Sorry, that's all we've gotfor now...

Northwest Biotherapeutics (NWBO) stock price today is 0.15 USD on OTC Markets OTCQB (-1.29% on the day). Updated .

Northwest Biotherapeutics NWBO Financial and Trading Overview

Northwest Biotherapeutics stock price 0.15 USD
Previous Close 0.15 USD
Open 0.15 USD
Bid 0.15 USD x 1206500
Ask 0.16 USD x 1000000
Day's Range 0.15 - 0.16 USD
52 Week Range 0.14 - 0.34 USD
Volume 699.05K USD
Avg. Volume 4.33M USD
Market Cap 256.7M USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -0.03 USD
Forward Dividend & Yield N/A (0%)
Ex-Dividend Date N/A
1y Target Est 1 USD

NWBO Valuation Measures

Enterprise Value 344.24M USD
Trailing P/E N/A
Forward P/E -2.15
PEG Ratio (5 yr expected) 1.72
Price/Sales (ttm) 89.88044
Price/Book (mrq) N/A
Enterprise Value/Revenue 120.531
Enterprise Value/EBITDA -8.027

Trading Information

Northwest Biotherapeutics Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -37.50%
S&P500 52-Week Change 10.51%
52 Week High 0.34 USD
52 Week Low 0.14 USD
50-Day Moving Average 0.16 USD
200-Day Moving Average 0.19 USD

NWBO Share Statistics

Avg. Volume (3 month) 4.33M USD
Avg. Daily Volume (10-Days) 4.51M USD
Shares Outstanding 1.71B
Float 1.74B
Short Ratio 4.76
% Held by Insiders 3.86%
% Held by Institutions 0.12%
Shares Short 11.1M
Short % of Float 11.83%
Short % of Shares Outstanding 8.89%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:16

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2025
Most Recent Quarter (mrq) September 30, 2026
Next Fiscal Year End December 31, 2026

Profitability

Profit Margin 0%
Operating Margin (ttm) -1608.82%
Gross Margin 0%
EBITDA Margin 0%

Management Effectiveness

Return on Assets (ttm) -53.80%
Return on Equity (ttm) N/A

Income Statement

Revenue (ttm) 2.86M USD
Revenue Per Share (ttm) 0.002 USD
Quarterly Revenue Growth (yoy) 341.50%
Gross Profit (ttm) -17483000 USD
EBITDA -42883000 USD
Net Income Avi to Common (ttm) -40711000 USD
Diluted EPS (ttm) -0.03
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 725K USD
Total Cash Per Share (mrq) 0 USD
Total Debt (mrq) 69.84M USD
Total Debt/Equity (mrq) N/A
Current Ratio (mrq) 0.027
Book Value Per Share (mrq) -0.032

Cash Flow Statement

Operating Cash Flow (ttm) -43200000 USD
Levered Free Cash Flow (ttm) -37940624 USD

Profile of Northwest Biotherapeutics

Country United States
State MD
City Bethesda
Address 4800 Montgomery Lane
ZIP 20814
Phone 240 497 9024
Website https://www.nwbio.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 105

Northwest Biotherapeutics, Inc., a biotechnology company, engages in the development of personalized immune therapies for cancer. The company develops DCVax, a platform technology which uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. It also engages in the development of its lead product candidate DCVax-L in Phase III trials for glioblastoma multiforme brain cancer. In addition, the company develops DCVax-Direct in Phase I trials to treat inoperable solid tumors. Northwest Biotherapeutics, Inc. was founded in 1996 and is headquartered in Bethesda, Maryland.

Q&A For Northwest Biotherapeutics Stock

What is a current NWBO stock price?

Northwest Biotherapeutics NWBO stock price today per share is 0.15 USD.

How to purchase Northwest Biotherapeutics stock?

You can buy NWBO shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Northwest Biotherapeutics?

The stock symbol or ticker of Northwest Biotherapeutics is NWBO.

Which industry does the Northwest Biotherapeutics company belong to?

The Northwest Biotherapeutics industry is Biotechnology.

How many shares does Northwest Biotherapeutics have in circulation?

The max supply of Northwest Biotherapeutics shares is 1.71B.

What is Northwest Biotherapeutics Price to Earnings Ratio (PE Ratio)?

Northwest Biotherapeutics PE Ratio is now.

What was Northwest Biotherapeutics earnings per share over the trailing 12 months (TTM)?

Northwest Biotherapeutics EPS is -0.03 USD over the trailing 12 months.

Which sector does the Northwest Biotherapeutics company belong to?

The Northwest Biotherapeutics sector is Healthcare.

Northwest Biotherapeutics NWBO included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
us US Tech Composite Total Return XCMP US 30190.38 USD —
+0.42
— — 29937.56 USD — 30324.94 USD — — — —
$2.17T
Total marketcap
$71.96B
Total volume
BTC 58.01%   •   ETH 9.98%
Dominance
Select currency